Discontinuation Syndrome With JAK2 Selective Agents: Case Presentation and Mechanistic Insights
JCO Precision Oncology · 2024-02 · (8)
DOI: 10.1200/po.23.00234 ↗Kurz gefasst
Fallbericht in der Zeitschrift JCO Precision Oncology, 2024-02. Verfasst von Shivani Handa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY. Hauptthemen laut MEDLINE: Primary Myelofibrosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
We report the first case of pacritinib-withdrawal syndrome with in vitro elucidation of underlying mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
- Department of Pharmacy Practice, The Mount Sinai Hospital, New York, NY.
- Department of Pathology, Molecular & Cell-Based Medicine, Icahn School of Medicine, The Mount Sinai Hospital, New York, NY.
ORCID-Profile: Shivani Handa, Michelle Becker, Ashley Yu, Christian Salib, John Mascarenhas, Alan H Shih
Zitieren
APA
Handa, S., Farina, K. A., Becker, M., Kelly, B., Yu, A., Feld, J., Tremblay, D., Marcellino, B. K., Salib, C., Mascarenhas, J., & Shih, A. H. (2024). Discontinuation Syndrome With JAK2 Selective Agents: Case Presentation and Mechanistic Insights. JCO Precision Oncology. https://doi.org/10.1200/po.23.00234
Vancouver
Handa S, Farina KA, Becker M, Kelly B, Yu A, Feld J, et al. Discontinuation Syndrome With JAK2 Selective Agents: Case Presentation and Mechanistic Insights. JCO Precision Oncology. 2024. doi:10.1200/po.23.00234
BibTeX
@article{Handa2024,
author = {Handa, Shivani and Farina, Kyle A and Becker, Michelle and Kelly, Brianna and Yu, Ashley and Feld, Jonathan and Tremblay, Douglas and Marcellino, Bridget K and Salib, Christian and Mascarenhas, John and Shih, Alan H},
title = {Discontinuation Syndrome With JAK2 Selective Agents: Case Presentation and Mechanistic Insights},
journal = {JCO Precision Oncology},
year = {2024},
number = {8},
doi = {10.1200/po.23.00234}
}
EUVIMED